BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tripathi RP, Tewari N, Dwivedi N, Tiwari VK. Fighting tuberculosis: An old disease with new challenges. Med Res Rev 2005;25:93-131. [DOI: 10.1002/med.20017] [Cited by in Crossref: 152] [Cited by in F6Publishing: 156] [Article Influence: 8.4] [Reference Citation Analysis]
Number Citing Articles
1 Alotaibi SH. Study of drug interaction, mutant frequency and mutant prevention concentration of DFMBT against Mycobacterium tuberculosis H37RV. Microb Pathog 2023;:106023. [PMID: 36736799 DOI: 10.1016/j.micpath.2023.106023] [Reference Citation Analysis]
2 Sharma A, Agrahari AK, Rajkhowa S, Tiwari VK. Emerging impact of triazoles as anti-tubercular agent. Eur J Med Chem 2022;238:114454. [PMID: 35597009 DOI: 10.1016/j.ejmech.2022.114454] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Honmore VS, Natu AD, Khedkar VM, Sarkar D, Rojatkar SR. Flavonoids from Alpinia officinarum as Potential Anti-Tubercular Agents Using Molecular Docking Studies. Asian J Chem 2022;34:937-944. [DOI: 10.14233/ajchem.2022.23620] [Reference Citation Analysis]
4 Meeran IS, Raja TW, Dusthakeer VNA, Ali MMN, Tajudeen SS, Shabeer TK. An insight into antimycobacterial and antioxidant potentials of INH-Schiff base complexes and in silico targeting of MtKasB receptor of M. tuberculosis. New J Chem 2022;46:4620-33. [DOI: 10.1039/d1nj04977a] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Davies-bolorunduro OF, Ajayi A, Adeleye IA, Kristanti AN, Aminah NS. Bioprospecting for antituberculosis natural products – A review. Open Chemistry 2021;19:1074-88. [DOI: 10.1515/chem-2021-0095] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Guerrero Manriquez GG, Tuero I. Adjuvants: friends in vaccine formulations against infectious diseases. Hum Vaccin Immunother 2021;:1-12. [PMID: 34288795 DOI: 10.1080/21645515.2021.1934354] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Tiwari VK. Development of Diverse Range of Biologically Relevant Carbohydrate-Containing Molecules: Twenty Years of Our Journey*. Chem Rec 2021. [PMID: 34047444 DOI: 10.1002/tcr.202100058] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
8 Musiyak VV, Nizova IA, Chulakov EN, Sadretdinova LS, Tumashov AA, Levit GL, Krasnov VP. Stereochemical aspects in the synthesis of novel N-(purin-6-yl)dipeptides as potential antimycobacterial agents. Amino Acids 2021;53:407-15. [PMID: 33599833 DOI: 10.1007/s00726-021-02958-0] [Reference Citation Analysis]
9 Reddy DS, Kongot M, Kumar A. Coumarin hybrid derivatives as promising leads to treat tuberculosis: Recent developments and critical aspects of structural design to exhibit anti-tubercular activity. Tuberculosis (Edinb) 2021;127:102050. [PMID: 33540334 DOI: 10.1016/j.tube.2020.102050] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
10 Mondal M, Pawar A, Sahoo K, Kumar D. Utilization of Natural Compounds for Treatment of Tuberculosis-I. Medicinal Plants for Lung Diseases 2021. [DOI: 10.1007/978-981-33-6850-7_7] [Reference Citation Analysis]
11 Yuanita E, Sudirman, Dharmayani NKT, Ulfa M, Syahri J. Quantitative structure-activity relationship (QSAR) and molecular docking of xanthone derivatives as anti-tuberculosis agents. J Clin Tuberc Other Mycobact Dis 2020;21:100203. [PMID: 33294629 DOI: 10.1016/j.jctube.2020.100203] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
12 Mohamed NA, Abd El‐ghany NA, Fahmy MM, Abdel‐aziz MM. Phthalimido thioureas with high antimicrobial performance as stabilizers for enhancement of the thermal stability of poly(vinyl chloride) loaded with multi‐walled carbon nanotubes. Polym Adv Technol 2021;32:1317-32. [DOI: 10.1002/pat.5179] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
13 Mishra N, Tiwari VK, Schmidt RR. Recent trends and challenges on carbohydrate-based molecular scaffolding: general consideration toward impact of carbohydrates in drug discovery and development. Carbohydrates in Drug Discovery and Development 2020. [DOI: 10.1016/b978-0-12-816675-8.00001-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
14 Adeniji SE, Uba S, Uzairu A. Quantitative structure–activity relationship and molecular docking of 4-Alkoxy-Cinnamic analogues as anti-mycobacterium tuberculosis. Journal of King Saud University - Science 2020;32:67-74. [DOI: 10.1016/j.jksus.2018.02.005] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
15 Bouz G, Semelková L, Janďourek O, Konečná K, Paterová P, Navrátilová L, Kubíček V, Kuneš J, Doležal M, Zitko J. Derivatives of 3-Aminopyrazine-2-carboxamides: Synthesis, Antimicrobial Evaluation, and in Vitro Cytotoxicity. Molecules 2019;24:E1212. [PMID: 30925695 DOI: 10.3390/molecules24071212] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
16 Reyes-rodríguez GJ, Rezayee NM, Vidal-albalat A, Jørgensen KA. Prevalence of Diarylprolinol Silyl Ethers as Catalysts in Total Synthesis and Patents. Chem Rev 2019;119:4221-60. [DOI: 10.1021/acs.chemrev.8b00583] [Cited by in Crossref: 74] [Cited by in F6Publishing: 77] [Article Influence: 18.5] [Reference Citation Analysis]
17 Das R, Asthana GS, Suri KA, Mehta D, Asthana A. Recent Developments in Azole Compounds as Antitubercular Agent. MROC 2019;16:290-306. [DOI: 10.2174/1570193x15666180622144414] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
18 Hou XM, Wang CY, Gerwick WH, Shao CL. Marine natural products as potential anti-tubercular agents. Eur J Med Chem 2019;165:273-92. [PMID: 30685527 DOI: 10.1016/j.ejmech.2019.01.026] [Cited by in Crossref: 40] [Cited by in F6Publishing: 40] [Article Influence: 10.0] [Reference Citation Analysis]
19 Musiyak VV, Gruzdev DA, Kravchenko MA, Vakhrusheva DV, Levit GL, Krasnov VP, Charushin VN. Synthesis and antimycobacterial activity of purine conjugates with (S)-lysine and (S)-ornithine. Mendeleev Communications 2019;29:11-3. [DOI: 10.1016/j.mencom.2019.01.002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
20 Orief M, Abdel-rhman M. Molecular modeling, spectroscopic and structural studies on newly synthesized ligand N-benzoyl-2-isonicotinoylhydrazine-1-carboxamide. Journal of Molecular Structure 2018;1173:332-40. [DOI: 10.1016/j.molstruc.2018.05.107] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
21 Adeniji SE, Uba S, Uzairu A. Theoretical modeling and molecular docking simulation for investigating and evaluating some active compounds as potent anti-tubercular agents against MTB CYP121 receptor. Future Journal of Pharmaceutical Sciences 2018;4:284-95. [DOI: 10.1016/j.fjps.2018.10.003] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 2.4] [Reference Citation Analysis]
22 Danne AB, Choudhari AS, Sarkar D, Sangshetti JN, Khedkar VM, Shingate BB. Synthesis and biological evaluation of novel triazole-biscoumarin conjugates as potential antitubercular and anti-oxidant agents. Res Chem Intermed 2018;44:6283-310. [DOI: 10.1007/s11164-018-3490-1] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
23 . 2,2-Dimethylbenzopyrans. Privileged Structures in Drug Discovery 2018. [DOI: 10.1002/9781118686263.ch11] [Reference Citation Analysis]
24 . 1,4-Dihydropyridines. Privileged Structures in Drug Discovery 2018. [DOI: 10.1002/9781118686263.ch3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
25 Kusuma SAF, Iskandar Y, Dewanti MA. The ethanolic extract of ashitaba stem (Angelica keskei [Miq.] Koidz) as future antituberculosis. J Adv Pharm Technol Res 2018;9:37-41. [PMID: 29441323 DOI: 10.4103/japtr.JAPTR_283_17] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
26 Gruzdev DA, Chulakov EN, Levit GL, Kravchenko MA, Krasnov VP, Charushin VN. Synthesis and antimycobacterial activity of novel purin-6-yl and 2-aminopurin-6-yl conjugates with ( S )-aspartic and ( S )-glutamic acids. Mendeleev Communications 2017;27:547-9. [DOI: 10.1016/j.mencom.2017.11.002] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
27 Mishra SK, Tripathi G, Kishore N, Singh RK, Singh A, Tiwari VK. Drug development against tuberculosis: Impact of alkaloids. European Journal of Medicinal Chemistry 2017;137:504-44. [DOI: 10.1016/j.ejmech.2017.06.005] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 5.7] [Reference Citation Analysis]
28 dos Santos ER, Corrêa RS, Pozzi LV, Graminha AE, Selistre-de-araújo HS, Pavan FR, Batista AA. Antitumor and anti-Mycobacterium tuberculosis agents based on cationic ruthenium complexes with amino acids. Inorganica Chimica Acta 2017;463:1-6. [DOI: 10.1016/j.ica.2017.04.012] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
29 Chavan PV, Pandit KS, Desai UV, Wadgaonkar PP, Nawale L, Bhansali S, Sarkar D. Click-chemistry-based multicomponent condensation approach for design and synthesis of spirochromene-tethered 1,2,3-triazoles as potential antitubercular agents. Res Chem Intermed 2017;43:5675-90. [DOI: 10.1007/s11164-017-2955-y] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
30 Patrushev SS, Rybalova TV, Ivanov ID, Vavilin VA, Shults EE. Synthesis of a new class of bisheterocycles via the Heck reaction of eudesmane type methylene lactones with 8-bromoxanthines. Tetrahedron 2017;73:2717-26. [DOI: 10.1016/j.tet.2017.03.016] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
31 Dheer D, Singh V, Shankar R. Medicinal attributes of 1,2,3-triazoles: Current developments. Bioorg Chem 2017;71:30-54. [PMID: 28126288 DOI: 10.1016/j.bioorg.2017.01.010] [Cited by in Crossref: 475] [Cited by in F6Publishing: 498] [Article Influence: 79.2] [Reference Citation Analysis]
32 Saharan VD, Mahajan SS. Development of gallic acid formazans as novel enoyl acyl carrier protein reductase inhibitors for the treatment of tuberculosis. Bioorg Med Chem Lett 2017;27:808-15. [PMID: 28117201 DOI: 10.1016/j.bmcl.2017.01.026] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
33 Bernuci KZ, Iwanaga CC, Fernadez-Andrade CM, Lorenzetti FB, Torres-Santos EC, Faiões VD, Gonçalves JE, do Amaral W, Deschamps C, Scodro RB, Cardoso RF, Baldin VP, Cortez DA. Evaluation of Chemical Composition and Antileishmanial and Antituberculosis Activities of Essential Oils of Piper Species. Molecules 2016;21:E1698. [PMID: 27973453 DOI: 10.3390/molecules21121698] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 5.3] [Reference Citation Analysis]
34 Keri RS, Rajappa CK, Patil SA, Nagaraja BM. Benzimidazole-core as an antimycobacterial agent. Pharmacological Reports 2016;68:1254-65. [DOI: 10.1016/j.pharep.2016.08.002] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 4.7] [Reference Citation Analysis]
35 Matviiuk T, Madacki J, Mori G, Orena BS, Menendez C, Kysil A, André-barrès C, Rodriguez F, Korduláková J, Mallet-ladeira S, Voitenko Z, Pasca MR, Lherbet C, Baltas M. Pyrrolidinone and pyrrolidine derivatives: Evaluation as inhibitors of InhA and Mycobacterium tuberculosis. European Journal of Medicinal Chemistry 2016;123:462-75. [DOI: 10.1016/j.ejmech.2016.07.028] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 3.4] [Reference Citation Analysis]
36 Karpov P, Іnstitute of Food Biotechnology and Genomics, NAS of Ukraine, Kyiv, Demchuk O, Britsun V, Lytvyn D, Pydiura M, Rayevsky O, Samofalova D, Spivak S, Volochnyuk D, Yemets A, Blume Y, Іnstitute of Food Biotechnology and Genomics, NAS of Ukraine, Kyiv, Institute of Organic Chemistry, NAS of Ukraine, Kyiv, Іnstitute of Food Biotechnology and Genomics, NAS of Ukraine, Kyiv, Іnstitute of Food Biotechnology and Genomics, NAS of Ukraine, Kyiv, Іnstitute of Food Biotechnology and Genomics, NAS of Ukraine, Kyiv, Іnstitute of Food Biotechnology and Genomics, NAS of Ukraine, Kyiv, Іnstitute of Food Biotechnology and Genomics, NAS of Ukraine, Kyiv, Institute of Organic Chemistry, NAS of Ukraine, Kyiv, Іnstitute of Food Biotechnology and Genomics, NAS of Ukraine, Kyiv, Іnstitute of Food Biotechnology and Genomics, NAS of Ukraine, Kyiv. New Imidazole Inhibitors of Mycobacterial FtsZ: the Way from High-Throughput Molecular Screening in Grid up to in vitro Verification. Nauka innov 2016;12:44-59. [DOI: 10.15407/scin12.03.044] [Reference Citation Analysis]
37 Karpov P, Demchuk O, Britsun V, Lytvyn D, Pydiura N, Rayevsky A, Samofalova D, Spivak S, Volochnyuk D, Yemets A, Blume Y; Institute of Food Biotechnology and Genomics, the NAS of Ukraine, Kyiv, Institute of Food Biotechnology and Genomics, the NAS of Ukraine, Kyiv, Institute of Organic Chemistry, NAS of Ukraine, Kyiv, Institute of Food Biotechnology and Genomics, the NAS of Ukraine, Kyiv, Institute of Food Biotechnology and Genomics, the NAS of Ukraine, Kyiv, Institute of Food Biotechnology and Genomics, the NAS of Ukraine, Kyiv, Institute of Food Biotechnology and Genomics, the NAS of Ukraine, Kyiv, Institute of Food Biotechnology and Genomics, the NAS of Ukraine, Kyiv, Institute of Organic Chemistry, NAS of Ukraine, Kyiv, Institute of Food Biotechnology and Genomics, the NAS of Ukraine, Kyiv, Institute of Food Biotechnology and Genomics, the NAS of Ukraine, Kyiv. New Imidazole Inhibitors of Mycobacterial FtsZ: the Way from High-Throughput Molecular Screening in Grid up to in vitro Verification. Sci innov 2016;12:43-55. [DOI: 10.15407/scine12.03.043] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
38 Rodríguez Arce E, Mosquillo MF, Pérez-Díaz L, Echeverría GA, Piro OE, Merlino A, Coitiño EL, Maríngolo Ribeiro C, Leite CQ, Pavan FR, Otero L, Gambino D. Aromatic amine N-oxide organometallic compounds: searching for prospective agents against infectious diseases. Dalton Trans 2015;44:14453-64. [PMID: 26203896 DOI: 10.1039/c5dt00557d] [Cited by in Crossref: 33] [Cited by in F6Publishing: 34] [Article Influence: 4.7] [Reference Citation Analysis]
39 Anand R. Identification of Potential Antituberculosis Drugs Through Docking and Virtual Screening. Interdiscip Sci Comput Life Sci 2018;10:419-29. [DOI: 10.1007/s12539-016-0175-6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.1] [Reference Citation Analysis]
40 Ghiya S, Joshi YC. Synthesis and antimicrobial evaluation of hydrazones derived from 4-methylbenzenesulfonohydrazide in aqueous medium. Med Chem Res 2016;25:970-6. [DOI: 10.1007/s00044-016-1543-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
41 Tiwari VK, Mishra BB, Mishra KB, Mishra N, Singh AS, Chen X. Cu-Catalyzed Click Reaction in Carbohydrate Chemistry. Chem Rev 2016;116:3086-240. [PMID: 26796328 DOI: 10.1021/acs.chemrev.5b00408] [Cited by in Crossref: 509] [Cited by in F6Publishing: 519] [Article Influence: 72.7] [Reference Citation Analysis]
42 Mishra S, Upadhaya K, Mishra KB, Shukla AK, Tripathi RP, Tiwari VK. Carbohydrate-Based Therapeutics. Studies in Natural Products Chemistry 2016. [DOI: 10.1016/b978-0-444-63601-0.00010-7] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 3.9] [Reference Citation Analysis]
43 Plutín AM, Alvarez A, Mocelo R, Ramos R, Castellano EE, da Silva MM, Colina-vegas L, Pavan FR, Batista AA. Anti- Mycobacterium tuberculosis activity of platinum(II)/ N , N -disubstituted- N ′-acyl thiourea complexes. Inorganic Chemistry Communications 2016;63:74-80. [DOI: 10.1016/j.inoche.2015.11.020] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 4.7] [Reference Citation Analysis]
44 Ramprasad J, Nayak N, Dalimba U. Design of new phenothiazine-thiadiazole hybrids via molecular hybridization approach for the development of potent antitubercular agents. Eur J Med Chem 2015;106:75-84. [PMID: 26520841 DOI: 10.1016/j.ejmech.2015.10.035] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 2.5] [Reference Citation Analysis]
45 Ramprasad J, Nayak N, Dalimba U, Yogeeswari P, Sriram D. One-pot synthesis of new triazole—Imidazo[2,1-b][1,3,4]thiadiazole hybrids via click chemistry and evaluation of their antitubercular activity. Bioorganic & Medicinal Chemistry Letters 2015;25:4169-73. [DOI: 10.1016/j.bmcl.2015.08.009] [Cited by in Crossref: 49] [Cited by in F6Publishing: 49] [Article Influence: 6.1] [Reference Citation Analysis]
46 Yadava U, Shukla BK, Roychoudhury M. Pyrazolo[3,4-d]pyrimidines as the inhibitors of mycobacterial β-oxidation trifunctional enzyme. Med Chem Res 2015;24:4002-15. [DOI: 10.1007/s00044-015-1441-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
47 Pore VS, Divse JM, Charolkar CR, Nawale LU, Khedkar VM, Sarkar D. Design and synthesis of 11α-substituted bile acid derivatives as potential anti-tuberculosis agents. Bioorg Med Chem Lett 2015;25:4185-90. [PMID: 26299346 DOI: 10.1016/j.bmcl.2015.08.006] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]
48 Suman P, Dayakar C, Rajkumar K, Yashwanth B, Yogeeswari P, Sriram D, Rao JV, Raju BC. Synthesis and anti-mycobacterial activity of 2-chloronicotinaldehydes based novel 1H-1,2,3-triazolylbenzohydrazides. Bioorganic & Medicinal Chemistry Letters 2015;25:2390-4. [DOI: 10.1016/j.bmcl.2015.04.009] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
49 Elhakeem MA, Taher AT, Abuel-maaty SM. Synthesis and anti-mycobacterial evaluation of some new isonicotinylhydrazide analogues. Bulletin of Faculty of Pharmacy, Cairo University 2015;53:45-52. [DOI: 10.1016/j.bfopcu.2014.11.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
50 Saxena S, Samala G, Sridevi JP, Devi PB, Yogeeswari P, Sriram D. Design and development of novel Mycobacterium tuberculosis l-alanine dehydrogenase inhibitors. European Journal of Medicinal Chemistry 2015;92:401-14. [DOI: 10.1016/j.ejmech.2014.12.046] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 3.4] [Reference Citation Analysis]
51 Pereira L, Diogo J, Mateus R, Pimentel M, Videira M. Host-directed strategies using lipid nanoparticles to reduce mycobacteria survival. J Nanopart Res 2015;17. [DOI: 10.1007/s11051-015-2892-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
52 Bhagyasree J, Varghese HT, Panicker CY, Van Alsenoy C, Al-saadi AA, Dolezal M, Samuel J. Spectroscopic (FT-IR, FT-Raman), first order hyperpolarizability, NBO analysis, HOMO and LUMO analysis of 5-tert-Butyl-6-chloro-N-[(4-(trifluoromethyl)phenyl]pyrazine-2-carboxamide. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 2015;137:193-206. [DOI: 10.1016/j.saa.2014.08.104] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
53 Barbosa MI, Corrêa RS, Pozzi LV, Lopes ÉDO, Pavan FR, Leite CQ, Ellena J, Machado SDP, Poelhsitz GV, Batista AA. Ruthenium(II) complexes with hydroxypyridinecarboxylates: Screening potential metallodrugs against Mycobacterium tuberculosis. Polyhedron 2015;85:376-82. [DOI: 10.1016/j.poly.2014.08.057] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 2.4] [Reference Citation Analysis]
54 Kumar JK, Devi Prasad AG, Chaturvedi V. Phytochemical screening of five medicinal legumes and their evaluation for in vitro anti-tubercular activity. Ayu 2014;35:98-102. [PMID: 25364208 DOI: 10.4103/0974-8520.141952] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
55 Correia I, Adão P, Roy S, Wahba M, Matos C, Maurya MR, Marques F, Pavan FR, Leite CQF, Avecilla F, Costa Pessoa J. Hydroxyquinoline derived vanadium(IV and V) and copper(II) complexes as potential anti-tuberculosis and anti-tumor agents. J Inorg Biochem 2014;141:83-93. [PMID: 25226436 DOI: 10.1016/j.jinorgbio.2014.07.019] [Cited by in Crossref: 101] [Cited by in F6Publishing: 102] [Article Influence: 11.2] [Reference Citation Analysis]
56 Xu S, Li D, Pei L, Yao H, Wang C, Cai H, Yao H, Wu X, Xu J. Design, synthesis and antimycobacterial activity evaluation of natural oridonin derivatives. Bioorganic & Medicinal Chemistry Letters 2014;24:2811-4. [DOI: 10.1016/j.bmcl.2014.04.119] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 3.2] [Reference Citation Analysis]
57 Voynikov Y, Valcheva V, Momekov G, Peikov P, Stavrakov G. Theophylline-7-acetic acid derivatives with amino acids as anti-tuberculosis agents. Bioorganic & Medicinal Chemistry Letters 2014;24:3043-5. [DOI: 10.1016/j.bmcl.2014.05.026] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 3.0] [Reference Citation Analysis]
58 Araujo RC, Neves FA, Formagio AS, Kassuya CA, Stefanello ME, Souza VV, Pavan FR, Croda J. Evaluation of the anti-mycobacterium tuberculosis activity and in vivo acute toxicity of Annona sylvatic. BMC Complement Altern Med 2014;14:209. [PMID: 24974069 DOI: 10.1186/1472-6882-14-209] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.0] [Reference Citation Analysis]
59 Khunt RC, Khedkar VM, Coutinho EC. Synthesis and 3D-QSAR analysis of 2-chloroquinoline derivatives as H37 RV MTB inhibitors. Chem Biol Drug Des 2013;82:669-84. [PMID: 23790070 DOI: 10.1111/cbdd.12178] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
60 Crick DC, Brennan PJ. Biosynthesis of the Arabinogalactan-Peptidoglycan Complex ofMycobacterium tuberculosiss. The Mycobacterial Cell Envelope 2014. [DOI: 10.1128/9781555815783.ch3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
61 Mahajan A, Hans R, Chibale K, Kumar V. Synthesis and medicinal chemistry of selected antitubercular natural products and natural product derivatives. RSC Adv 2014;4:15180. [DOI: 10.1039/c3ra46124f] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
62 Banerjee DR, Dutta D, Saha B, Bhattacharyya S, Senapati K, Das AK, Basak A. Design, synthesis and characterization of novel inhibitors against mycobacterial β-ketoacyl CoA reductase FabG4. Org Biomol Chem 2014;12:73-85. [DOI: 10.1039/c3ob41676c] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
63 Singh SP, Konwar BK, Bezbaruah RL, Bora TC. Molecular docking and in silico studies on analogues of 2-methylheptyl isonicotinate with DHDPS enzyme of Mycobacterium tuberculosis. Med Chem Res 2013;22:4755-4765. [DOI: 10.1007/s00044-013-0488-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
64 Lemétais A, Bourdreux Y, Lesot P, Farjon J, Beau J. Synthesis of a Mycobacterium tuberculosis Tetra-acylated Sulfolipid Analogue and Characterization of the Chiral Acyl Chains Using Anisotropic NAD 2D-NMR Spectroscopy. J Org Chem 2013;78:7648-57. [DOI: 10.1021/jo4012255] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.9] [Reference Citation Analysis]
65 Asif M. Tuberculosis: Treatment-related Problems and Future Facets. Arch Clin Infect Dis 2013;8. [DOI: 10.5812/archcid.14413] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
66 El Ashry el SH, El Tamany el SH, Fattah Mel D, Aly MR, Boraei AT, Duerkop A. A new synthetic access to 2-N-(glycosyl)thiosemicarbazides from 3-N-(glycosyl)oxadiazolinethiones and the regioselectivity of the glycosylation of their oxadiazolinethione precursors. Beilstein J Org Chem 2013;9:135-46. [PMID: 23400104 DOI: 10.3762/bjoc.9.16] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
67 Kumar K, Carrère-kremer S, Kremer L, Guérardel Y, Biot C, Kumar V. Azide–alkynecycloadditionen route towards 1H-1,2,3-triazole-tethered β-lactam–ferrocene and β-lactam–ferrocenylchalcone conjugates: synthesis and in vitro anti-tubercular evaluation. Dalton Trans 2013;42:1492-500. [DOI: 10.1039/c2dt32148c] [Cited by in Crossref: 44] [Cited by in F6Publishing: 45] [Article Influence: 4.4] [Reference Citation Analysis]
68 Kerr PG. Plants and Tuberculosis. Fighting Multidrug Resistance with Herbal Extracts, Essential Oils and Their Components 2013. [DOI: 10.1016/b978-0-12-398539-2.00005-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
69 Chiranjeevi B, Koyyada G, Prabusreenivasan S, Kumar V, Sujitha P, Kumar CG, Sridhar B, Shaik S, Chandrasekharam M. Iron-catalyzed aryl-aryl cross coupling route for the synthesis of 1-(2-amino)-phenyl)dibenzo[b,d]furan-2-ol derivatives and their biological evaluation. RSC Adv 2013;3:16475. [DOI: 10.1039/c3ra43345e] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 2.1] [Reference Citation Analysis]
70 Huang W, Gauld JW. Tautomerization in the UDP-galactopyranose mutase mechanism: a DFT-cluster and QM/MM investigation. J Phys Chem B 2012;116:14040-50. [PMID: 23148701 DOI: 10.1021/jp310952c] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
71 Moura KC, Carneiro PF, Pinto MDCF, da Silva JA, Malta VR, de Simone CA, Dias GG, Jardim GA, Cantos J, Coelho TS, da Silva PEA, da Silva EN. 1,3-Azoles from ortho-naphthoquinones: Synthesis of aryl substituted imidazoles and oxazoles and their potent activity against Mycobacterium tuberculosis. Bioorganic & Medicinal Chemistry 2012;20:6482-8. [DOI: 10.1016/j.bmc.2012.08.041] [Cited by in Crossref: 39] [Cited by in F6Publishing: 38] [Article Influence: 3.5] [Reference Citation Analysis]
72 Yan M, Ma S. Recent Advances in the Research of Heterocyclic Compounds as Antitubercular Agents. ChemMedChem 2012;7:2063-75. [DOI: 10.1002/cmdc.201200339] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 2.0] [Reference Citation Analysis]
73 Sharma A, Subbias KK, Robine O, Chaturvedi I, Nigam A, Sharma N, Chaudhary PP. Computational finding of potential inhibitor for Cytochrome P450 Mono-oxygenases Enzyme of Mycobacterium tuberculosis. Bioinformation 2012;8:931-7. [PMID: 23144553 DOI: 10.6026/97320630008931] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
74 Alp H, Cirit U, Tas M, Rifaioglu MM, Hatipoglu NK, Aytekin I, Yucel M, Firat U, Ozmen MF, Seker U, Eren LB. Effects of Sildenafil Citrate, Isoniazid, and Streptomycin on Testicular Tissue and Epididymal Semen Quality in Rats. Urology 2012;80:953.e9-953.e14. [DOI: 10.1016/j.urology.2012.05.016] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
75 Sandoval-Montemayor NE, García A, Elizondo-Treviño E, Garza-González E, Alvarez L, del Rayo Camacho-Corona M. Chemical composition of hexane extract of Citrus aurantifolia and anti-Mycobacterium tuberculosis activity of some of its constituents. Molecules 2012;17:11173-84. [PMID: 22992784 DOI: 10.3390/molecules170911173] [Cited by in Crossref: 53] [Cited by in F6Publishing: 56] [Article Influence: 4.8] [Reference Citation Analysis]
76 Crandall PG, Ricke SC, O'Bryan CA, Parrish NM. In vitro effects of citrus oils against Mycobacterium tuberculosis and non-tuberculous Mycobacteria of clinical importance. J Environ Sci Health B 2012;47:736-41. [PMID: 22560037 DOI: 10.1080/03601234.2012.669331] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
77 Macingwana L, Baker B, Ngwane AH, Harper C, Cotton MF, Hesseling A, Diacon AH, van Helden P, Wiid I. Sulfamethoxazole enhances the antimycobacterial activity of rifampicin. Journal of Antimicrobial Chemotherapy 2012;67:2908-11. [DOI: 10.1093/jac/dks306] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 1.8] [Reference Citation Analysis]
78 Boechat N, de Lourdes G. Ferreira M, Bastos MM, da Silva GP, Wardell SMSV, Wardell J. Structures of 1-(substituted-phenyl)-4-hydroxymethyl- and -4-fluoromethyl-1,2,3-triazoles. Zeitschrift für Kristallographie 2012;227:369-378. [DOI: 10.1524/zkri.2012.1481] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
79 Beena, Rawat DS. Antituberculosis Drug Research: A Critical Overview: ANTITUBERCULOSIS DRUG RESEARCH. Med Res Rev 2013;33:693-764. [DOI: 10.1002/med.21262] [Cited by in Crossref: 102] [Cited by in F6Publishing: 104] [Article Influence: 9.3] [Reference Citation Analysis]
80 Tekwu EM, Askun T, Kuete V, Nkengfack AE, Nyasse B, Etoa FX, Beng VP. Antibacterial activity of selected Cameroonian dietary spices ethno-medically used against strains of Mycobacterium tuberculosis. J Ethnopharmacol 2012;142:374-82. [PMID: 22595661 DOI: 10.1016/j.jep.2012.05.003] [Cited by in Crossref: 43] [Cited by in F6Publishing: 45] [Article Influence: 3.9] [Reference Citation Analysis]
81 García A, Bocanegra-garcía V, Palma-nicolás JP, Rivera G. Recent advances in antitubercular natural products. European Journal of Medicinal Chemistry 2012;49:1-23. [DOI: 10.1016/j.ejmech.2011.12.029] [Cited by in Crossref: 139] [Cited by in F6Publishing: 141] [Article Influence: 12.6] [Reference Citation Analysis]
82 Liu Y, Zhong W, Li S. Syntheses and studies of hydantoin derivatives as potential anti-tuberculosis inhibitors. Chinese Chemical Letters 2012;23:133-6. [DOI: 10.1016/j.cclet.2011.11.017] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
83 Parekh NM, Maheria KC. Antituberculosis and antibacterial evaluations of some novel phenyl pyrazolone-substituted 1h-benzo[g]pyrazolo[3,4-b]quinoline-3-ylamine derivatives. Med Chem Res 2012;21:4168-76. [DOI: 10.1007/s00044-011-9942-4] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
84 Kukshal V, Mishra M, Ajay A, Khanam T, Sharma R, Dube D, Chopra D, Tripathi RP, Ramachandran R. Synthesis and bioevaluation of aryl hydroxamates distinguishing between NAD+ and ATP-dependent DNA ligases. Med Chem Commun 2012;3:453. [DOI: 10.1039/c2md00168c] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
85 de Prince KA, Sordi R, Pavan FR, Barreto Santos AC, Araujo AR, Leite SR, Leite CQ. Anti-Mycobacterium tuberculosis activity of fungus Phomopsis stipata. Braz J Microbiol 2012;43:224-9. [PMID: 24031821 DOI: 10.1590/S1517-838220120001000024] [Reference Citation Analysis]
86 Kumar K, Singh P, Kremer L, Guérardel Y, Biot C, Kumar V. Synthesis and in vitro anti-tubercular evaluation of 1,2,3-triazole tethered β-lactam–ferrocene and β-lactam–ferrocenylchalcone chimeric scaffolds. Dalton Trans 2012;41:5778. [DOI: 10.1039/c2dt30514c] [Cited by in Crossref: 48] [Cited by in F6Publishing: 48] [Article Influence: 4.4] [Reference Citation Analysis]
87 Asif M. Study of clinically used and recently developed antimycobacterial agents. Orient Pharm Exp Med 2012;12:15-34. [DOI: 10.1007/s13596-011-0020-8] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
88 Fustero S, Cuñat AC, Flores S, Báez C, Oliver J, Cynamon M, Gütschow M, Mertens MD, Delgado O, Tresadern G, Trabanco AA. Design, Synthesis, and Biological Evaluation of Novel Fluorinated Ethanolamines. Chem Eur J 2011;17:14772-84. [DOI: 10.1002/chem.201102078] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
89 Shanmugavelan P, Nagarajan S, Sathishkumar M, Ponnuswamy A, Yogeeswari P, Sriram D. Efficient synthesis and in vitro antitubercular activity of 1,2,3-triazoles as inhibitors of Mycobacterium tuberculosis. Bioorg Med Chem Lett 2011;21:7273-6. [PMID: 22061642 DOI: 10.1016/j.bmcl.2011.10.048] [Cited by in Crossref: 78] [Cited by in F6Publishing: 81] [Article Influence: 6.5] [Reference Citation Analysis]
90 Pavan FR, Poelhsitz GV, Barbosa MI, Leite SR, Batista AA, Ellena J, Sato LS, Franzblau SG, Moreno V, Gambino D, Leite CQ. Ruthenium(II) phosphine/diimine/picolinate complexes: Inorganic compounds as agents against tuberculosis. European Journal of Medicinal Chemistry 2011;46:5099-107. [DOI: 10.1016/j.ejmech.2011.08.023] [Cited by in Crossref: 62] [Cited by in F6Publishing: 63] [Article Influence: 5.2] [Reference Citation Analysis]
91 Trivedi A, Dodiya D, Dholariya B, Kataria V, Bhuva V, Shah V. Synthesis and Biological Evaluation of Some Novel 1,4-Dihydropyridines as Potential AntiTubercular Agents: Synthesis and Biological Evaluation of Some Novel 1,4-Dihydropyridines. Chemical Biology & Drug Design 2011;78:881-6. [DOI: 10.1111/j.1747-0285.2011.01233.x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 2.2] [Reference Citation Analysis]
92 Marrapu VK, Chaturvedi V, Singh S, Singh S, Sinha S, Bhandari K. Novel aryloxy azolyl chalcones with potent activity against Mycobacterium tuberculosis H37Rv. European Journal of Medicinal Chemistry 2011;46:4302-10. [DOI: 10.1016/j.ejmech.2011.06.037] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 1.9] [Reference Citation Analysis]
93 Trivedi AR, Dodiya DK, Dholariya BH, Kataria VB, Bhuva VR, Shah VH. Synthesis and biological evaluation of some novel N-aryl-1,4-dihydropyridines as potential antitubercular agents. Bioorganic & Medicinal Chemistry Letters 2011;21:5181-3. [DOI: 10.1016/j.bmcl.2011.07.068] [Cited by in Crossref: 35] [Cited by in F6Publishing: 28] [Article Influence: 2.9] [Reference Citation Analysis]
94 Boechat N, Ferreira VF, Ferreira SB, Ferreira MDLG, da Silva FDC, Bastos MM, Costa MDS, Lourenço MCS, Pinto AC, Krettli AU, Aguiar AC, Teixeira BM, da Silva NV, Martins PRC, Bezerra FAFM, Camilo ALS, da Silva GP, Costa CCP. Novel 1,2,3-Triazole Derivatives for Use against Mycobacterium tuberculosis H37Rv (ATCC 27294) Strain. J Med Chem 2011;54:5988-99. [DOI: 10.1021/jm2003624] [Cited by in Crossref: 209] [Cited by in F6Publishing: 217] [Article Influence: 17.4] [Reference Citation Analysis]
95 Patel NB, Khan IH. Synthesis of 1,2,4-triazole derivatives containing benzothiazoles as pharmacologically active molecule. Journal of Enzyme Inhibition and Medicinal Chemistry 2011;26:527-34. [DOI: 10.3109/14756366.2010.535794] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
96 Trivedi AR, Dholariya BH, Vakhariya CP, Dodiya DK, Ram HK, Kataria VB, Siddiqui AB, Shah VH. Synthesis and anti-tubercular evaluation of some novel pyrazolo[3,4-d]pyrimidine derivatives. Med Chem Res 2012;21:1887-91. [DOI: 10.1007/s00044-011-9712-3] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 2.9] [Reference Citation Analysis]
97 Higuchi CT, Sannomiya M, Pavan FR, Leite SR, Sato DN, Franzblau SG, Sacramento LV, Vilegas W, Leite CQ. Byrsonima fagifolia Niedenzu Apolar Compounds with Antitubercular Activity. Evid Based Complement Alternat Med 2011;2011:128349. [PMID: 19091782 DOI: 10.1093/ecam/nen077] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
98 Chen Y, Huang S, Sun F, Chiang Y, Chiang C, Tsai C, Weng C. Transformation of cinnamic acid from trans- to cis-form raises a notable bactericidal and synergistic activity against multiple-drug resistant Mycobacterium tuberculosis. European Journal of Pharmaceutical Sciences 2011;43:188-94. [DOI: 10.1016/j.ejps.2011.04.012] [Cited by in Crossref: 77] [Cited by in F6Publishing: 78] [Article Influence: 6.4] [Reference Citation Analysis]
99 Gambino D, Fernández M, Santos D, Etcheverría GA, Piro OE, Pavan FR, Leite CQ, Tomaz I, Marques F. Searching for gallium bioactive compounds: Gallium(III) complexes of tridentate salicylaldehyde semicarbazone derivatives. Polyhedron 2011;30:1360-6. [DOI: 10.1016/j.poly.2011.02.037] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 2.6] [Reference Citation Analysis]
100 Suhas R, Chandrashekar S, Gowda DC. Synthesis of elastin based peptides conjugated to benzisoxazole as a new class of potent antimicrobials – A novel approach to enhance biocompatibility. European Journal of Medicinal Chemistry 2011;46:704-11. [DOI: 10.1016/j.ejmech.2010.12.005] [Cited by in Crossref: 40] [Cited by in F6Publishing: 40] [Article Influence: 3.3] [Reference Citation Analysis]
101 Tripathi RP, Pandey J, Kukshal V, Ajay A, Mishra M, Dube D, Chopra D, Dwivedi R, Chaturvedi V, Ramachandran R. Synthesis, in silico screening and bioevaluation of dispiro-cycloalkanones as antitubercular and mycobacterial NAD+-dependent DNA ligase inhibitors. Med Chem Commun 2011;2:378. [DOI: 10.1039/c0md00246a] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
102 Bisht SS, Dwivedi N, Chaturvedi V, Anand N, Misra M, Sharma R, Kumar B, Dwivedi R, Singh S, Sinha SK, Gupta V, Mishra P, Dwivedi AK, Tripathi RP. Synthesis and optimization of antitubercular activities in a series of 4-(aryloxy)phenyl cyclopropyl methanols. European Journal of Medicinal Chemistry 2010;45:5965-78. [DOI: 10.1016/j.ejmech.2010.09.063] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
103 Tarallo MB, Urquiola C, Monge A, Costa BP, Ribeiro RR, Costa-filho AJ, Mercader RC, Pavan FR, Leite CQ, Torre MH, Gambino D. Design of novel iron compounds as potential therapeutic agents against tuberculosis. Journal of Inorganic Biochemistry 2010;104:1164-70. [DOI: 10.1016/j.jinorgbio.2010.07.005] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 2.1] [Reference Citation Analysis]
104 Ajay A, Singh V, Singh S, Pandey S, Gunjan S, Dubey D, Sinha SK, Singh BN, Chaturvedi V, Tripathi R, Ramchandran R, Tripathi RP. Synthesis and bio-evaluation of alkylaminoaryl phenyl cyclopropyl methanones as antitubercular and antimalarial agents. Bioorg Med Chem 2010;18:8289-301. [PMID: 21041091 DOI: 10.1016/j.bmc.2010.09.071] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 1.8] [Reference Citation Analysis]
105 Trivedi AR, Bhuva VR, Dholariya BH, Dodiya DK, Kataria VB, Shah VH. Novel dihydropyrimidines as a potential new class of antitubercular agents. Bioorganic & Medicinal Chemistry Letters 2010;20:6100-2. [DOI: 10.1016/j.bmcl.2010.08.046] [Cited by in Crossref: 65] [Cited by in F6Publishing: 55] [Article Influence: 5.0] [Reference Citation Analysis]
106 Negi AS, Kumar JK, Luqman S, Saikia D, Khanuja SP. Antitubercular potential of plants: a brief account of some important molecules. Med Res Rev 2010;30:603-45. [PMID: 19626592 DOI: 10.1002/med.20170] [Cited by in Crossref: 6] [Cited by in F6Publishing: 12] [Article Influence: 0.5] [Reference Citation Analysis]
107 Tripathi RP, Bisht SS, Pandey VP, Pandey SK, Singh S, Sinha SK, Chaturvedi V. Search of antimycobacterial activities in hybrid molecules with benzopyran skeleton. Med Chem Res 2011;20:1515-22. [DOI: 10.1007/s00044-010-9402-6] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
108 Pavan FR, Poelhsitz GV, do Nascimento FB, Leite SR, Batista AA, Deflon VM, Sato DN, Franzblau SG, Leite CQ. Ruthenium (II) phosphine/picolinate complexes as antimycobacterial agents. European Journal of Medicinal Chemistry 2010;45:598-601. [DOI: 10.1016/j.ejmech.2009.10.049] [Cited by in Crossref: 38] [Cited by in F6Publishing: 38] [Article Influence: 2.9] [Reference Citation Analysis]
109 Crick DC, Chatterjee D, Scherman MS, Mcneil MR. Structure and Biosynthesis of the Mycobacterial Cell Wall. Comprehensive Natural Products II 2010. [DOI: 10.1016/b978-008045382-8.00173-8] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
110 Nicolaou KC, Sarlah D, Wu TR, Zhan W. Total synthesis of hirsutellone B. Angew Chem Int Ed Engl 2009;48:6870-4. [PMID: 19685548 DOI: 10.1002/anie.200903382] [Cited by in Crossref: 97] [Cited by in F6Publishing: 95] [Article Influence: 6.9] [Reference Citation Analysis]
111 Mao J, Yuan H, Wang Y, Wan B, Pieroni M, Huang Q, van Breemen RB, Kozikowski AP, Franzblau SG. From Serendipity to Rational Antituberculosis Drug Discovery of Mefloquine-Isoxazole Carboxylic Acid Esters. J Med Chem 2009;52:6966-78. [DOI: 10.1021/jm900340a] [Cited by in Crossref: 74] [Cited by in F6Publishing: 78] [Article Influence: 5.3] [Reference Citation Analysis]
112 Nicolaou K, Sarlah D, Wu T, Zhan W. Total Synthesis of Hirsutellone B. Angew Chem 2009;121:7002-6. [DOI: 10.1002/ange.200903382] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
113 Correia C, Carvalho MA, Proença MF. Synthesis and in vitro activity of 6-amino-2,9-diarylpurines for Mycobacterium tuberculosis. Tetrahedron 2009;65:6903-11. [DOI: 10.1016/j.tet.2009.06.065] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.2] [Reference Citation Analysis]
114 Hill K, Pénzes CB, Vértessy BG, Szabadka Z, Grolmusz V, Kiss É. Amphiphilic Nature of New Antitubercular Drug Candidates and Their Interaction With Lipid Monolayer. Colloids for Nano- and Biotechnology. [DOI: 10.1007/2882_2008_117] [Reference Citation Analysis]
115 Ko J, Chang C, Yang Y, Chen S. Rapid Determination of Ciprofloxacin in Cerebrospinal Fluid by Micellar Electrokinetic Chromatography with Direct Sample Injection and its Application in Tuberculosis Meningitis. Journal of Liquid Chromatography & Related Technologies 2009;32:418-31. [DOI: 10.1080/10826070802634513] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
116 Kishore N, Mishra BB, Tripathi V, Tiwari VK. Alkaloids as potential anti-tubercular agents. Fitoterapia 2009;80:149-63. [PMID: 19344681 DOI: 10.1016/j.fitote.2009.01.002] [Cited by in Crossref: 55] [Cited by in F6Publishing: 41] [Article Influence: 3.9] [Reference Citation Analysis]
117 [DOI: 10.1109/csie.2009.552] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
118 Zhu ZJ, Krasnykh O, Pan D, Petukhova V, Yu G, Liu Y, Liu H, Hong S, Wang Y, Wan B, Liang W, Franzblau SG. Structure-activity relationships of macrolides against Mycobacterium tuberculosis. Tuberculosis (Edinb) 2008;88 Suppl 1:S49-63. [PMID: 18762153 DOI: 10.1016/S1472-9792(08)70036-2] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.1] [Reference Citation Analysis]
119 Stalford SA, Fascione MA, Sasindran SJ, Chatterjee D, Dhandayuthapani S, Turnbull WB. A natural carbohydrate substrate for Mycobacterium tuberculosis methionine sulfoxide reductase A. Chem Commun (Camb) 2009;:110-2. [PMID: 19082015 DOI: 10.1039/b817483k] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
120 Koçyiğit-kaymakçıoğlu B, Elçin Oruç-emre E, Unsalan S, Rollas S. Antituberculosis activity of hydrazones derived from 4-fluorobenzoic acid hydrazide. Med Chem Res 2009;18:277-86. [DOI: 10.1007/s00044-008-9126-z] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 1.4] [Reference Citation Analysis]
121 Letafat B, Emami S, Aliabadi A, Mohammadhosseini N, Moshafi MH, Asadipour A, Shafiee A, Foroumadi A. Synthesis and in-vitro antibacterial activity of 5-substituted 1-methyl-4-nitro-1H-imidazoles. Arch Pharm (Weinheim). 2008;341:497-501. [PMID: 18618489 DOI: 10.1002/ardp.200800022] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
122 Saxena N, Singh N, Mishra M, Shiva Keshava GB, Shukla PK, Tripathi RP. Synthesis of azatricyclodiones & octahydro-benzo[f]isoindoles and their antimicrobial evaluation. Journal of Enzyme Inhibition and Medicinal Chemistry 2008;23:476-82. [DOI: 10.1080/14756360701709383] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
123 do Nascimento FB, Von Poelhsitz G, Pavan FR, Sato DN, Leite CQ, Selistre-de-araújo HS, Ellena J, Castellano EE, Deflon VM, Batista AA. Synthesis, characterization, X-ray structure and in vitro antimycobacterial and antitumoral activities of Ru(II) phosphine/diimine complexes containing the “SpymMe2” ligand, SpymMe2=4,6-dimethyl-2-mercaptopyrimidine. Journal of Inorganic Biochemistry 2008;102:1783-9. [DOI: 10.1016/j.jinorgbio.2008.05.009] [Cited by in Crossref: 43] [Cited by in F6Publishing: 44] [Article Influence: 2.9] [Reference Citation Analysis]
124 Metwally NH. A Convenient Synthesis of Some New 5-Substituted-4-Thioxo-Thiazolidinones and Fused Thiopyrano[2,3- d ]thiazole Derivatives. Phosphorus, Sulfur, and Silicon and the Related Elements 2008;183:2073-85. [DOI: 10.1080/10426500701849105] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
125 Liautard V, Desvergnes V, Itoh K, Liu H, Martin OR. Convergent and Stereoselective Synthesis of Iminosugar-Containing Gal f and UDP-Gal f Mimicks:  Evaluation as Inhibitors of UDP-Gal Mutase. J Org Chem 2008;73:3103-15. [DOI: 10.1021/jo8001134] [Cited by in Crossref: 57] [Cited by in F6Publishing: 57] [Article Influence: 3.8] [Reference Citation Analysis]
126 Crick DC, Quadri L, Brennan PJ. Biochemistry of the Cell Envelope of Mycobacterium tuberculosis. In: Kaufmann SHE, Rubin E, Britton WJ, Helden P, editors. Handbook of Tuberculosis. Wiley; 2008. pp. 1-19. [DOI: 10.1002/9783527611614.ch1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
127 Proszenyák A, Charnock C, Hedner E, Larsson R, Bohlin L, Gundersen LL. Synthesis, antimicrobial and antineoplastic activities for agelasine and agelasimine analogs with a beta-cyclocitral derived substituent. Arch Pharm (Weinheim) 2007;340:625-34. [PMID: 17994607 DOI: 10.1002/ardp.200700137] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 2.0] [Reference Citation Analysis]
128 Dolezal M, Tůmová L, Kesetovicová D, Tůma J, Králová K. Substituted N-phenylpyrazine-2-carboxamides, their synthesis and evaluation as herbicides and abiotic elicitors. Molecules 2007;12:2589-98. [PMID: 18259145 DOI: 10.3390/12122589] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 1.1] [Reference Citation Analysis]
129 Sankaranarayanan R, Cherney MM, Cherney LT, Garen CR, Moradian F, James MN. The crystal structures of ornithine carbamoyltransferase from Mycobacterium tuberculosis and its ternary complex with carbamoyl phosphate and L-norvaline reveal the enzyme's catalytic mechanism. J Mol Biol 2008;375:1052-63. [PMID: 18062991 DOI: 10.1016/j.jmb.2007.11.025] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 0.9] [Reference Citation Analysis]
130 Braendvang M, Gundersen LL. Synthesis, biological activity, and SAR of antimycobacterial 2- and 8-substituted 6-(2-furyl)-9-(p-methoxybenzyl)purines. Bioorg Med Chem 2007;15:7144-65. [PMID: 17804243 DOI: 10.1016/j.bmc.2007.07.034] [Cited by in Crossref: 49] [Cited by in F6Publishing: 45] [Article Influence: 3.1] [Reference Citation Analysis]
131 ter Horst B, Feringa BL, Minnaard AJ. Catalytic Asymmetric Synthesis of Phthioceranic Acid, a Heptamethyl-Branched Acid from Mycobacterium tuberculosis. Org Lett 2007;9:3013-5. [DOI: 10.1021/ol071078o] [Cited by in Crossref: 91] [Cited by in F6Publishing: 93] [Article Influence: 5.7] [Reference Citation Analysis]
132 Mao J, Wan B, Wang Y, Franzblau S, Kozikowski A. HTS, Chemical Hybridization, and Drug Design Identify a Chemically Unique Antituberculosis Agent–Coupling Serendipity and Rational Approaches to Drug Discovery. ChemMedChem 2007;2:811-3. [DOI: 10.1002/cmdc.200700048] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 1.3] [Reference Citation Analysis]
133 Vik A, Hedner E, Charnock C, Tangen LW, Samuelsen Ø, Larsson R, Bohlin L, Gundersen L. Antimicrobial and cytotoxic activity of agelasine and agelasimine analogs. Bioorganic & Medicinal Chemistry 2007;15:4016-37. [DOI: 10.1016/j.bmc.2007.03.086] [Cited by in Crossref: 70] [Cited by in F6Publishing: 60] [Article Influence: 4.4] [Reference Citation Analysis]
134 Gautam R, Saklani A, Jachak SM. Indian medicinal plants as a source of antimycobacterial agents. Journal of Ethnopharmacology 2007;110:200-34. [DOI: 10.1016/j.jep.2006.12.031] [Cited by in Crossref: 161] [Cited by in F6Publishing: 170] [Article Influence: 10.1] [Reference Citation Analysis]
135 Zjawiony JK. Antitubercular Activity of Mushrooms (Basidiomycetes) and their Metabolites. Natural Product Communications 2007;2:1934578X0700200. [DOI: 10.1177/1934578x0700200314] [Reference Citation Analysis]
136 Copp BR, Pearce AN. Natural product growth inhibitors of Mycobacterium tuberculosis. Nat Prod Rep 2007;24:278-97. [DOI: 10.1039/b513520f] [Cited by in Crossref: 129] [Cited by in F6Publishing: 135] [Article Influence: 8.1] [Reference Citation Analysis]
137 Bai B, Xie J, Yan J, Wang H, Hu C. A high throughput screening approach to identify isocitrate lyase inhibitors from traditional Chinese medicine sources. Drug Dev Res 2006;67:818-23. [DOI: 10.1002/ddr.20152] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
138 Tripathi R, Saxena N, Tiwari V, Verma S, Chaturvedi V, Manju Y, Srivastva A, Gaikwad A, Sinha S. Synthesis and antitubercular activity of substituted phenylmethyl- and pyridylmethyl amines. Bioorganic & Medicinal Chemistry 2006;14:8186-96. [DOI: 10.1016/j.bmc.2006.09.020] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 1.1] [Reference Citation Analysis]
139 Tripathi R, Verma S, Pandey J, Agarwal K, Chaturvedi V, Manju Y, Srivastva A, Gaikwad A, Sinha S. Search of antitubercular activities in tetrahydroacridines: Synthesis and biological evaluation. Bioorganic & Medicinal Chemistry Letters 2006;16:5144-7. [DOI: 10.1016/j.bmcl.2006.07.025] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 1.6] [Reference Citation Analysis]
140 Prazeres VF, Sánchez-sixto C, Castedo L, Canales Á, Cañada F, Jiménez-barbero J, Lamb H, Hawkins A, González-bello C. Determination of the Bound Conformation of a Competitive Nanomolar Inhibitor ofMycobacterium tuberculosis Type II Dehydroquinase by NMR Spectroscopy. ChemMedChem 2006;1:990-6. [DOI: 10.1002/cmdc.200600100] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
141 Grech K, Watt K, Read AF. Host–parasite interactions for virulence and resistance in a malaria model system. J Evolution Biol 2006;19:1620-30. [DOI: 10.1111/j.1420-9101.2006.01116.x] [Cited by in Crossref: 64] [Cited by in F6Publishing: 64] [Article Influence: 3.8] [Reference Citation Analysis]
142 Costa MS, Boechat N, Rangel EA, da Silva Fde C, de Souza AM, Rodrigues CR, Castro HC, Junior IN, Lourenço MC, Wardell SM, Ferreira VF. Synthesis, tuberculosis inhibitory activity, and SAR study of N-substituted-phenyl-1,2,3-triazole derivatives. Bioorg Med Chem 2006;14:8644-53. [PMID: 16949290 DOI: 10.1016/j.bmc.2006.08.019] [Cited by in Crossref: 162] [Cited by in F6Publishing: 164] [Article Influence: 9.5] [Reference Citation Analysis]
143 Prado S, Ledeit H, Michel S, Koch M, Darbord JC, Cole ST, Tillequin F, Brodin P. Benzofuro[3,2-f][1]benzopyrans: A new class of antitubercular agents. Bioorganic & Medicinal Chemistry 2006;14:5423-8. [DOI: 10.1016/j.bmc.2006.03.033] [Cited by in Crossref: 50] [Cited by in F6Publishing: 50] [Article Influence: 2.9] [Reference Citation Analysis]
144 Jayaprakash S, Iso Y, Wan B, Franzblau S, Kozikowski A. Design, Synthesis, and SAR Studies of Mefloquine-Based Ligands as Potential Antituberculosis Agents. ChemMedChem 2006;1:593-7. [DOI: 10.1002/cmdc.200600010] [Cited by in Crossref: 82] [Cited by in F6Publishing: 83] [Article Influence: 4.8] [Reference Citation Analysis]
145 Kovala-demertzi D. Recent advances on non-steroidal anti-inflammatory drugs, NSAIDs: Organotin complexes of NSAIDs. Journal of Organometallic Chemistry 2006;691:1767-74. [DOI: 10.1016/j.jorganchem.2005.11.058] [Cited by in Crossref: 103] [Cited by in F6Publishing: 86] [Article Influence: 6.1] [Reference Citation Analysis]
146 Foroumadi A, Kargar Z, Sakhteman A, Sharifzadeh Z, Feyzmohammadi R, Kazemi M, Shafiee A. Synthesis and antimycobacterial activity of some alkyl [5-(nitroaryl)-1,3,4-thiadiazol-2-ylthio]propionates. Bioorganic & Medicinal Chemistry Letters 2006;16:1164-7. [DOI: 10.1016/j.bmcl.2005.11.087] [Cited by in Crossref: 50] [Cited by in F6Publishing: 52] [Article Influence: 2.9] [Reference Citation Analysis]
147 De Oliveira J, Seleghim M, Timm C, Grube A, Köck M, Nascimento G, Martins A, Silva E, De Souza A, Minarini P, Galetti F, Silva C, Hajdu E, Berlinck R. Antimicrobial and Antimycobacterial Activity of Cyclostellettamine Alkaloids from Sponge Pachychalina sp. Marine Drugs 2006;4:1-8. [DOI: 10.3390/md401001] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 1.5] [Reference Citation Analysis]
148 Marco-contelles J, Gómez-sánchez E. New Agents with Antimycobacterial Activity. Arch Pharm Chem Life Sci 2005;338:562-3. [DOI: 10.1002/ardp.200500133] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
149 Pauli GF, Case RJ, Inui T, Wang Y, Cho S, Fischer NH, Franzblau SG. New perspectives on natural products in TB drug research. Life Sci 2005;78:485-94. [PMID: 16243360 DOI: 10.1016/j.lfs.2005.09.004] [Cited by in Crossref: 88] [Cited by in F6Publishing: 89] [Article Influence: 4.9] [Reference Citation Analysis]
150 Tripathi R, Tiwari V, Tewari N, Katiyar D, Saxena N, Sinha S, Gaikwad A, Srivastava A, Chaturvedi V, Manju Y, Srivastava R, Srivastava B. Synthesis and antitubercular activities of bis-glycosylated diamino alcohols. Bioorganic & Medicinal Chemistry 2005;13:5668-79. [DOI: 10.1016/j.bmc.2005.05.021] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 1.5] [Reference Citation Analysis]
151 Dwivedi N, Tewari N, Tiwari V, Chaturvedi V, Manju Y, Srivastava A, Giakwad A, Sinha S, Tripathi R. An efficient synthesis of aryloxyphenyl cyclopropyl methanones: a new class of anti-mycobacterial agents. Bioorganic & Medicinal Chemistry Letters 2005;15:4526-30. [DOI: 10.1016/j.bmcl.2005.07.007] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 1.1] [Reference Citation Analysis]
152 Tripathi RP, Tewari N, Dwivedi N, Tiwari VK. Fighting Tuberculosis: An Old Disease with New Challenges. ChemInform 2005;36. [DOI: 10.1002/chin.200511291] [Reference Citation Analysis]